Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-HD: SD-809 for Chorea in Huntington Disease
NCT01795859Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of deutetrabenazine in Huntington's disease (HD), sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2013; status: completed.
02
Drugs
deutetrabenazine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT01795859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01795859.